SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yasuyuki Honjo, Hidefumi Ito, Tomohisa Horibe, Hiroyuki Shimada, Aki Nakanishi, Hiroshi Mori, Ryosuke Takahashi, Koji Kawakami, Derlin-1-immunopositive inclusions in patients with Alzheimer’s disease, NeuroReport, 2012, 23, 10, 611

    CrossRef

  2. 2
    Yu-Shan Lin, Gregory R. Bowman, Kyle A. Beauchamp, Vijay S. Pande, Investigating How Peptide Length and a Pathogenic Mutation Modify the Structural Ensemble of Amyloid Beta Monomer, Biophysical Journal, 2012, 102, 2, 315

    CrossRef

  3. You have free access to this content3
    Robert Jesky, Chen Hailong, Are Herbal Compounds the Next Frontier for Alleviating Learning and Memory Impairments? An Integrative Look at Memory, Dementia and the Promising Therapeutics of Traditional Chinese Medicines, Phytotherapy Research, 2011, 25, 8
  4. 4
    Amy L. Byers, Kristine Yaffe, Depression and risk of developing dementia, Nature Reviews Neurology, 2011, 7, 6, 323

    CrossRef

  5. 5
    Victoria A. Lawson, Helen M. Klemm, Jeremy M. Welton, Colin L. Masters, Peter Crouch, Roberto Cappai, Giuseppe D. Ciccotosto, Gene Knockout of tau Expression Does Not Contribute to the Pathogenesis of Prion Disease, Journal of Neuropathology and Experimental Neurology, 2011, 70, 11, 1036

    CrossRef

  6. 6
    Marcus O. W. Grimm, Sven Grösgen, Tatjana L. Rothhaar, Verena K. Burg, Benjamin Hundsdörfer, Viola J. Haupenthal, Petra Friess, Ulrike Müller, Klaus Fassbender, Matthias Riemenschneider, Heike S. Grimm, Tobias Hartmann, Intracellular APP Domain Regulates Serine-Palmitoyl-CoA Transferase Expression and Is Affected in Alzheimer's Disease, International Journal of Alzheimer's Disease, 2011, 2011, 1

    CrossRef

  7. 7
    Xingxuan He, Yu Huang, Bin Li, Cheng-Xin Gong, Edward H. Schuchman, Deregulation of sphingolipid metabolism in Alzheimer's disease, Neurobiology of Aging, 2010, 31, 3, 398

    CrossRef

  8. 8
    Yasuyuki Honjo, Hidefumi Ito, Tomohisa Horibe, Ryosuke Takahashi, Koji Kawakami, Protein disulfide isomerase-immunopositive inclusions in patients with Alzheimer disease, Brain Research, 2010, 1349, 90

    CrossRef

  9. 9
    Yeonsu Song, Glenna A. Dowling, Margaret I. Wallhagen, Kathryn A. Lee, William J. Strawbridge, Sleep in Older Adults With Alzheimer's Disease, Journal of Neuroscience Nursing, 2010, 42, 4, 190

    CrossRef

  10. 10
    Xianlin Han, The Pathogenic Implication of Abnormal Interaction Between Apolipoprotein E Isoforms, Amyloid-beta Peptides, and Sulfatides in Alzheimer’s Disease, Molecular Neurobiology, 2010, 41, 2-3, 97

    CrossRef

  11. 11
    Katsunori Fujio, Mahito Sato, Takefumi Uemura, Takashi Sato, Reiko Sato-Harada, Akihiro Harada, 14-3-3 proteins and protein phosphatases are not reduced in tau-deficient mice, NeuroReport, 2007, 18, 10, 1049

    CrossRef

  12. 12
    Takako Niikura, Humanin: a potential peptide for neuroprotective therapy against Alzheimer's disease, Expert Opinion on Drug Discovery, 2007, 2, 9, 1273

    CrossRef

  13. 13
    Xianlin Han, Potential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stage of Alzheimer’s disease: a tale of shotgun lipidomics, Journal of Neurochemistry, 2007, 103,
  14. 14
    B. Potier, A. Jouvenceau, J. Epelbaum, P. Dutar, Age-related alterations of GABAergic input to CA1 Pyramidal neurons and its control by nicotinic acetylcholine receptors in rat hippocampus, Neuroscience, 2006, 142, 1, 187

    CrossRef

  15. 15
    Natalia Traissard, Karine Herbeaux, Brigitte Cosquer, Hélène Jeltsch, Barbara Ferry, Rodrigue Galani, Anne Pernon, Monique Majchrzak, Jean-Christophe Cassel, Combined Damage to Entorhinal Cortex and Cholinergic Basal Forebrain Neurons, Two Early Neurodegenerative Features Accompanying Alzheimer's Disease: Effects on Locomotor Activity and Memory Functions in Rats, Neuropsychopharmacology, 2006, 32, 4, 851

    CrossRef

  16. 16
    Bernhard H Monien, Liana G Apostolova, Gal Bitan, Early diagnostics and therapeutics for Alzheimer’s disease – how early can we get there?, Expert Review of Neurotherapeutics, 2006, 6, 9, 1293

    CrossRef

  17. 17
    L. Migliore, G. Boni, R. Bernardini, F. Trippi, R. Colognato, I. Fontana, F. Coppedè, I. Sbrana, Susceptibility to chromosome malsegregation in lymphocytes of women who had a Down syndrome child in young age, Neurobiology of Aging, 2006, 27, 5, 710

    CrossRef

  18. 18
    Amy R. Borenstein, Yougui Wu, James A. Mortimer, Gerard D. Schellenberg, Wayne C. McCormick, James D. Bowen, Susan McCurry, Eric B. Larson, Developmental and vascular risk factors for Alzheimer's disease, Neurobiology of Aging, 2005, 26, 3, 325

    CrossRef

  19. 19
    Dalinda Liazoghli, Sebastien Perreault, Kristina D. Micheva, Mylène Desjardins, Nicole Leclerc, Fragmentation of the Golgi Apparatus Induced by the Overexpression of Wild-Type and Mutant Human Tau Forms in Neurons, The American Journal of Pathology, 2005, 166, 5, 1499

    CrossRef

  20. 20
    Davide Seripa, Maria G. Matera, Gloria Dal Forno, Carolina Gravina, Carlo Masullo, Antonio Daniele, Giuliano Binetti, Cristian Bonvicini, Rosanna Squitti, Mark T. Palermo, Daron G. Davis, P. Antuono, David R. Wekstein, Aldo Dobrina, Massimo Gennarelli, Vito M. Fazio, Genotypes and haplotypes in the IL-1 gene cluster: analysis of two genetically and diagnostically distinct groups of Alzheimer patients, Neurobiology of Aging, 2005, 26, 4, 455

    CrossRef

  21. 21
    JOSEPH L. LASKY, HONG WU, Notch Signaling, Brain Development, and Human Disease, Pediatric Research, 2005, 57, 5 Part 2, 104R

    CrossRef

  22. 22
    Tara L. Spires, Bradley T. Hyman, Transgenic models of Alzheimer’s disease: Learning from animals, NeuroRX, 2005, 2, 3, 423

    CrossRef

  23. 23
    Sungmin Song, Yong-Keun Jung, Alzheimer's disease meets the ubiquitin–proteasome system, Trends in Molecular Medicine, 2004, 10, 11, 565

    CrossRef

  24. 24
    Andrew Feigin, Evidence from biomarkers and surrogate endpoints, NeuroRX, 2004, 1, 3, 323

    CrossRef

  25. 25
    Andrew Feigin, Evidence from biomarkers and surrogate endpoints, Neurotherapeutics, 2004, 1, 3, 323

    CrossRef

  26. 26
    William Tatton, David Chen, Ruth Chalmers-Redman, Larry Wheeler, Ralph Nixon, Nadine Tatton, Hypothesis for a Common Basis for Neuroprotection in Glaucoma and Alzheimer's Disease, Survey of Ophthalmology, 2003, 48, 2, S25

    CrossRef

  27. 27
    Amy J. Hanson, Judith E. Prasad, Piruz Nahreini, Cynthia Andreatta, Bipin Kumar, Xiang-Dong Yan, Kedar N. Prasad, Overexpression of amyloid precursor protein is associated with degeneration, decreased viability, and increased damage caused by neurotoxins (prostaglandins A1 and E2, hydrogen peroxide, and nitric oxide) in differentiated neuroblastoma cells, Journal of Neuroscience Research, 2003, 74, 1
  28. 28
    Paul R Turner, Kate O’Connor, Warren P Tate, Wickliffe C Abraham, Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory, Progress in Neurobiology, 2003, 70, 1, 1

    CrossRef